ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,046Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1006

$1.19M Total Retail Price of All Prescriptions

Rank: 28 out of 1006

509 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,561 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 498 450 1 1
LEVOTHYROXINE SODIUM 461 397 2 2
OMEPRAZOLE 408 385 3 9
AMLODIPINE BESYLATE 388 359 4 4
FUROSEMIDE 343 322 5 6
ATORVASTATIN CALCIUM 342 323 6 5
LISINOPRIL 325 279 7 3
WARFARIN SODIUM 322 296 8 8
METOPROLOL TARTRATE 304 290 9 7
TRAZODONE HCL 286 270 10 21
GABAPENTIN 282 257 11 20
PREDNISONE 197 165 12 33
DONEPEZIL HCL 194 194 13 17
METFORMIN HCL 182 130 14 10
HYDROCHLOROTHIAZIDE 175 156 15 11
METOPROLOL SUCCINATE 170 133 16 12
CYMBALTA 169 165 17 41
ZOLPIDEM TARTRATE 168 141 18 14
MIRTAZAPINE 164 161 19 26
DIOVAN 147 136 20 16
NAMENDA 141 141 21 34
HYDROCODONE-ACETAMINOPHEN 136 114 S3 22 25
CARVEDILOL 128 119 23 36
ESCITALOPRAM OXALATE 128 124 23 27
KLOR-CON M20 127 117 25 70
RISPERIDONE 126 126 26 40
ADVAIR DISKUS 120 94 27 37
AZITHROMYCIN 113 97 28 39
POTASSIUM CHLORIDE 110 107 29 30
TAMSULOSIN HCL 110 110 29 23
LANTUS 110 101 29 43
QUETIAPINE FUMARATE 103 72 32 45
SERTRALINE HCL 103 102 32 19
CARBIDOPA-LEVODOPA 101 101 34 80
ALLOPURINOL 100 72 35 31
OLANZAPINE 100 89 35 68
ATENOLOL 97 94 37 13
NEXIUM 96 75 38 28
IBUPROFEN 95 59 39 114
ALENDRONATE SODIUM 91 81 40 29
LIDODERM 89 62 41 66
LIPITOR 88 84 42 47
DIGOXIN 83 83 43 52
CRESTOR 82 68 44 18
PAROXETINE HCL 76 64 45 62
CLOPIDOGREL 75 70 46 46
DIOVAN HCT 75 70 46 60
TRAMADOL HCL 75 67 46 35
JANUVIA 73 72 49 49
PANTOPRAZOLE SODIUM 71 59 50 32
GLIMEPIRIDE 65 50 51 50
CLOTRIMAZOLE-BETAMETHASONE 64 63 52 111
DIVALPROEX SODIUM 63 63 53 53
OXYBUTYNIN CHLORIDE ER 62 48 54 92
CIPROFLOXACIN HCL 62 52 54 75
FENOFIBRATE 61 54 56 109
CELEBREX 58 57 57 90
NOVOLOG 58 58 57 94
LOSARTAN POTASSIUM 58 53 57 22
LEVETIRACETAM 57 38 60 72
HYDROXYZINE HCL 56 52 R 61 189
ZETIA 55 52 62 51
LEVEMIR FLEXPEN 55 43 62 173
CITALOPRAM HBR 54 52 64 24
LEVOFLOXACIN 53 49 65 96
PLAVIX 50 50 66 61
DEXILANT 50 35 66 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.